Trial Profile
Exploratory Study to Evaluate the Efficacy and Safety of CD5789 in Subjects with Acne
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Trifarotene (Primary) ; Adapalene/benzoyl peroxide
- Indications Acne vulgaris
- Focus Therapeutic Use
- 01 Apr 2022 Status changed from recruiting to completed.
- 25 Jun 2012 New trial record